Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess the effect of C21 on forearm blood flow by use of strain-gauge venous occlusion plethysmography.


Clinical Trial Description

Subject will be screened for eligibility. Eligible subjects will receive ascending doses of C21 (3, 10, 30 and 100 µg/min through locla i.a. infusions for 5 min/dose. Forearm blood flow measurements will be performed in both arms during the last 2 minutes of each dose. infusions of sodium nitroprusside will be performed as a positive control using the same methodology. ;


Study Design


NCT number NCT05277922
Study type Interventional
Source Vicore Pharma AB
Contact
Status Completed
Phase Phase 1
Start date April 28, 2022
Completion date May 20, 2022